The Cancer Center (HM CIOCC) uses state-of-the-art cancer treatments, including next-generation chemotherapy drugs.
Innovative cytostatics have a higher specificity and selectivity for tumor cells, have less effect on normal tissues and cause a minimum of side effects.
Also in the HM Hospitales clinic they use:
Immunotherapy is a type of cancer treatment based on enhancing the ability of the body’s immune system to recognize and attack tumor cells.
Hormone therapy – used to treat hormone-dependent tumors, control and reduce the level of hormones in the body, or to block the action of hormones on the tumor;
Targeted therapy – uses drugs that block certain molecules responsible for the growth and spread of the tumor.
Targeted therapy differs from classical chemotherapy in that it acts more precisely and selectively on tumor cells without damaging healthy tissues. Targeted therapies can be effective for a variety of cancers, such as lung, breast, stomach, and melanoma.
HM Hospitales also has its own laboratory for the molecular genetic analysis of tumors. The study helps in understanding the structure of the tumor, determining the prognosis of the disease and choosing the most effective treatment for a particular patient.
The leading method of treatment of malignant processes is surgical intervention. HM Hospitales employs highly qualified oncosurgeons who have extensive experience in performing various types of operations for cancer of the stomach, intestines, breast, lungs, kidneys, prostate and other organs.
HM Hospitales uses modern technologies and equipment, such as laparoscopy, robotic surgery, guided surgery. These methods allow to carry out operations with minimal traumatism, blood loss and the risk of complications. And also provide the best cosmetic effect and quick recovery of patients.